Onset of the COVID-19 pandemic reduced active time in patients with implanted cardiac devices

Nicholas Sommers1, Marcie Berger1, Jason C Rubenstein1

  • 1Medical College of Wisconsin, Milwaukee, WI, USA.

Insights

The COVID-19 pandemic significantly reduced physical activity in patients with permanent pacemakers (PPM) and implantable cardioverter-defibrillators (ICD). Less active patients experienced greater reductions, potentially increasing cardiovascular risks.

Area of Science:

  • Cardiology
  • Public Health
  • Medical Devices

Background:

  • Physical inactivity is a major risk factor for chronic diseases and mortality.
  • COVID-19 pandemic-related lifestyle changes may have exacerbated sedentary behavior.
  • Patients with cardiac implantable devices may be particularly vulnerable to activity changes.

Purpose of the Study:

  • To quantify the impact of the COVID-19 pandemic on physical activity levels in patients with permanent pacemakers (PPM) and implantable cardioverter-defibrillators (ICD).
  • To compare activity changes during the pandemic with pre-pandemic periods, accounting for aging and seasonality.
  • To explore the relationship between activity reduction and adverse health outcomes like hospital admissions.

Main Methods:

  • Retrospective analysis of accelerometry data from 332 PPM and 244 ICD patients across six time points.
  • Paired t-tests with Bonferroni correction were used for statistical comparisons between time periods.
  • Logistic regression analyses examined the association between activity reduction and hospital/emergency department admissions.

Main Results:

  • A significant decrease in daily active hours was observed during the pandemic period compared to the previous year for both PPM (0.53 ± 1.18h/day) and ICD (0.51 ± 1.2h/day) patients.
  • Patients with lower baseline activity (<2h/day), especially those with ICDs, showed a more pronounced reduction in activity.
  • A trend suggested increased hospital/ED admissions for PPM patients with greater activity reduction during the pandemic onset.

Conclusions:

  • The COVID-19 pandemic onset led to a significant decline in physical activity among PPM and ICD patients.
  • This activity reduction was more pronounced in less active individuals and was not attributable to aging or seasonal factors.
  • Sustained inactivity in these patient populations could lead to increased cardiovascular morbidity.
Abstract

Related Concept Videos

Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
896
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
27
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
155
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
22